DocDollars

Adaptive Biotechnologies Corporation

WA · United States · Reporting entity ID 100000486814

Total reported 2019–2025
$18.8M
#337 of 2,960 reporting companies — 0% of all reported industry payments
$2.86M in general payments across 14,308 records, plus $15.9M in research funding across 3,096 records.

How it breaks down

General payments $2,860,436
Research funding $15,906,244

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Adaptive Biotechnologies Corporation reported $18.8M to US doctors and teaching hospitals from 2019 to 2025, ranking #337 of 2,960 reporting companies. 85% of that was research funding and 15% general payments such as consulting, speaking, food and travel. 14,308 general payment records and 3,096 research records were filed.

Common questions about Adaptive Biotechnologies Corporation

How much has Adaptive Biotechnologies Corporation paid US doctors?

Adaptive Biotechnologies Corporation reported $18,766,680 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $2,860,436 in general payments, $15,906,244 in research funding.

How does Adaptive Biotechnologies Corporation rank among drug and device companies?

It ranks #337 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Adaptive Biotechnologies Corporation mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.